1 Relation between falciparum malaria and HIV seropositivity in Ndola, Zambia

2 Augmented antibody response to live attenuated measles vaccine in children with Plasmodium falciparum parasitaemia

3 Absence of association between Plasmodium falciparum malaria and human immunodeficiency virus infection in children in Kinshasa, Zaire

4 The search for plasmodium falciparum histidine-rich protein 2/3 deletions in Zambia and implications for plasmodium falciparum histidine-rich protein 2-based rapid diagnostic tests

5 Epidemiology of Plasmodium falciparum infection and drug resistance markers in Ota Area, Southwestern Nigeria

6 Profiles of hematological parameters in Plasmodium falciparum and Plasmodium vivax malaria patients attending Tercha General Hospital, Dawuro Zone, South Ethiopia

7 Prevalence of Plasmodium falciparum antimalarial drug resistance genes in Southeastern Gabon from 2011 to 2014

8 Assessing parasite clearance during uncomplicated Plasmodium falciparum infection treated with artesunate monotherapy in Suriname

9 Molecular analysis of markers associated with chloroquine and sulfadoxine/pyrimethamine resistance in Plasmodium falciparum malaria parasites from southeastern Côte-d'Ivoire by the time of Artemisinin-based Combination Therapy adoption in 2005

10 Epidemiology of Plasmodium falciparum infection and drug resistance markers in Ota Area, Southwestern Nigeria

11 Epidemiology of Plasmodium falciparum infection and drug resistance markers in Ota Area, Southwestern Nigeria

12 Profiles of hematological parameters in Plasmodium falciparum and Plasmodium vivax malaria patients attending Tercha General Hospital, Dawuro Zone, South Ethiopia

13 Prevalence of Plasmodium falciparum antimalarial drug resistance genes in Southeastern Gabon from 2011 to 2014

14 Multiple-Strain Malaria Infection and Its Impacts on Plasmodium falciparum Resistance to Antimalarial Therapy: A Mathematical Modelling Perspective

15 Assessing parasite clearance during uncomplicated Plasmodium falciparum infection treated with artesunate monotherapy in Suriname

16 Molecular analysis of markers associated with chloroquine and sulfadoxine/pyrimethamine resistance in Plasmodium falciparum malaria parasites from southeastern Côte-d'Ivoire by the time of Artemisinin-based Combination Therapy adoption in 2005

17 Correction: Antigenic cartography of immune responses to Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1).

18 Antigenic cartography of immune responses to Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1).

19 Extracellular vesicles carrying lactate dehydrogenase induce suicide in increased population density of Plasmodium falciparum in vitro

20 Characterization of the accessible genome in the human malaria parasite Plasmodium falciparum.

21 Safety and clinical outcome of experimental challenge of human volunteers with Plasmodium falciparum-infected mosquitoes: an update.

22 Prevalence of Plasmodium falciparum Pfcrt and Pfmdr1 alleles in settings with different levels of Plasmodium vivax co-endemicity in Ethiopia.

23 Pregnant Women: An Overlooked Asset to Plasmodium falciparum Malaria Elimination Campaigns?

24 Spatial mapping and prediction of Plasmodium falciparum infection risk among school-aged children in Côte d'Ivoire.

25 Adaptation of Plasmodium falciparum to humans involved the loss of an ape-specific erythrocyte invasion ligand.

26 Assessment of the Combined Effect of Epstein–Barr Virus and Plasmodium falciparum Infections on Endemic Burkitt Lymphoma Using a Multiplex Serological Approach

27 Human population, urban settlement patterns and their impact on Plasmodium falciparum malaria endemicity.

28 Infants' Peripheral Blood Lymphocyte Composition Reflects Both Maternal and Post-Natal Infection with Plasmodium falciparum.

29 Pan-Plasmodium band sensitivity for Plasmodium falciparum detection in combination malaria rapid diagnostic tests and implications for clinical management.

30 Operational accuracy and comparative persistent antigenicity of HRP2 rapid diagnostic tests for Plasmodium falciparum malaria in a hyperendemic region of Uganda.

31 Persistent histidine-rich protein 2, parasite lactate dehydrogenase, and panmalarial antigen reactivity after clearance of Plasmodium falciparum monoinfection.

32 Persistent ICT malaria P.f/P.v panmalarial and HRP2 antigen reactivity after treatment of Plasmodium falciparum malaria is associated with gametocytemia and results in false-positive diagnoses of Plasmodium vivax in convalescence.

33 Stabilization of chloroquine resistance in vivo of plasmodium falciparum in edea, south cameroon

34 Increase of chloroquine resistance in vivo of plasmodium falciparum over two years in edea, South Cameroon

35 In vivo study of amodiaquine sensitivity of Plasmodium falciparum in the town of Edea (Cameroon)

36 An Exported Heat Shock Protein 40 Associates with Pathogenesis-Related Knobs in Plasmodium falciparum Infected Erythrocytes

37 Prevalence of afebrile parasitaemia due to Plasmodium falciparum & P. vivax in district Balaghat (Madhya Pradesh): Implication for malaria control

38 Assessment of Antimalarial Activity against Plasmodium falciparum and Phytochemical Screening of Some Yemeni Medicinal Plants

39 The recognition of proteasomal receptors by Plasmodium falciparum DSK2.

40 Facile synthesis of vanillin-based novel bischalcones identifies one that induces apoptosis and displays synergy with Artemisinin in killing chloroquine resistant Plasmodium falciparum

41 Synthesis of new 4-Aminoquinolines and evaluation of their in vitro activity against chloroquine-sensitive and chloroquine-resistant plasmodium falciparum

42 Design, economical synthesis and antiplasmodial evaluation of vanillin derived allylated chalcones and their marked synergism with artemisinin against chloroquine resistant strains of Plasmodium falciparum

43 The multifaceted histone chaperone RbAp46/48 in Plasmodium falciparum: structural insights, production, and characterization.

44 The clinical and parasitological presentation of Plasmodium falciparum malaria in Uganda is unaffected by HIV-1 infection

45 Increased frequency of malaria attacks in subjects co-infected by intestinal worms and Plasmodium falciparum malaria

46 Out of Africa: origins and evolution of the human malaria parasites Plasmodium falciparum and Plasmodium vivax

47 Loss of cellular immune reactivity during acute Plasmodium falciparum malaria

48 Use of Peroxisome Proliferator-Activated Receptor γ Agonists as Adjunctive Treatment for Plasmodium falciparum Malaria: A Randomized, Double-Blind, Placebo-Controlled Trial

49 Antigen-Specific Immunosuppression in Human Malaria Due to Plasmodium falciparum

50 Antigen-specific immunosuppression in human malaria due to Plasmodium falciparum

51 Sensitive, highly multiplexed sequencing of microhaplotypes from the Plasmodium falciparum heterozygome

52 Increased frequency of malaria attacks in subjects co-infected by intestinal worms and Plasmodium falciparum malaria

53 assessment of clinical diagnosis, microscopy, rapid diagnostic tests, and polymerase chain reaction in the diagnosis of plasmodium falciparum in nigeria

54 delayed cerebellar ataxia: a rare self limiting complication of plasmodium falciparum malaria

55 hubungan kadar hemoglobin dengan respon sitokin proinflamasi dan anti inflamasi pada penderita infeksi plasmodium falciparum dan plasmodium vivax di timika, papua tahun 2010

56 a gbp 130 derived peptide from plasmodium falciparum binds to human erythrocytes and inhibits merozoite invasion in vitro

57 molecular detection of plasmodium falciparum infection in matched peripheral and placental blood samples from delivering women in libreville, gabon

58 prevalence of plasmodium falciparum malaria among pregnant students in dodoma region, tanzania: no cases have been detected

59 drug susceptibility of plasmodium falciparum in the western amazon region, state of acre, brazil susceptibilidade a droga, do plasmodium falciparum, na amazônia ocidental, estado do acre, brasil

60 chemoresistance of plasmodium falciparum and plasmodium vivax parasites in brazil: consequences on disease morbidity and control

61 chloroquine sensitivity of plasmodium falciparum in berakit, bintan island, sumatra, after mass chemoprophylaxis through community participation, and its sociological studies

62 high plasmodium falciparum longitudinal prevalence is associated with high multiclonality and reduced clinical malaria risk in a seasonal transmission area of mali.

63 mutations in plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase of isolates from the amazon region of brazil

64 mutaciones puntuales en los genes dhfr y dhps de plasmodium falciparum de tres regiones endémicas

65 pfgbp: una proteína de unión al telómero de plasmodium falciparum

66 in vitro chloroquine resistance in plasmodium falciparum isolates from tertiary care hospital

67 in-vitro antimalarial activity of azithromycin against chloroquine sensitive and chloroquine resistant plasmodium falciparum.

68 effects of drug policy changes on evolution of molecular markers of plasmodium falciparum resistance to chloroquine, amodiaquine, and sulphadoxine-pyrimethamine in the south west region of cameroon

69 gametocitemia en malaria por plasmodium falciparum tratada con amodiaquina o artesunato

70 análise da reatividade cruzada entre soros de pacientes com leishmaniose, doença de chagas ou toxoplasmose com antígenos de formas sanguíneas de plasmodium falciparum através do teste de imunofluorescência indireta

71 host-seeking behaviors of mosquitoes experimentally infected with sympatric field isolates of the human malaria parasite plasmodium falciparum: no evidence for host manipulation

72 alterations in cytokines and haematological parameters during the acute and convalescent phases of plasmodium falciparum and plasmodium vivax infections

73 seroepidemiologic assessment of malaria using an elisa for ring-infected erythrocyte surface antigen of plasmodium falciparum

74 eficacia terapéutica de tres esquemas de tratamiento de malaria no complicada por plasmodium falciparum, antioquia, colombia, 2002.

75 malaria vaccines: identifying plasmodium falciparum liver-stage targets

76 transgenic tomato plants expressing the antigen gene pfcp-2.9 of plasmodium falciparum

77 structure of the knob protein gene of the saimiri monkey-adapted palo alto strain of plasmodium falciparum

78 emprego da associação tetraciclina e quinino no tratamento da malária causada pelo plasmodium falciparum

79 pfcrt and pfmdr1 alleles associated with chloroquine resistance in plasmodium falciparum from guyana, south america

80 refined method for droplet microfluidics-enabled detection of plasmodium falciparum encoded topoisomerase i in blood from malaria patients

81 resistência à sulfadoxina-pirimetamina em maputo, moçambique: presença de mutações nos genes dhfr e dhps do plasmodium falciparum sulfadoxine-pyrimethamine resistance in maputo, mozambique: presence of mutations in the dhfr and dhps genes of plasmodium falciparum

82 risks of plasmodium falciparumparasitemia among 10 years or below children in indonesia: a 2010 national study

83 role and regulation of glutathione metabolism in plasmodium falciparum

84 The global distribution of clinical episodes of Plasmodium falciparum malaria - Nature

85 Complex nutrient channel phenotypes despite Mendelian inheritance in a Plasmodium falciparum genetic cross

86 Functional Comparison of Blood-Stage Plasmodium falciparum Malaria Vaccine Candidate Antigens

87 A case-control auditory evaluation of patients treated with artemisinin derivatives for multidrug-resistant Plasmodium falciparum malaria

88 Evaluation of CareStart™ malaria Pf/Pv combo test for Plasmodium falciparum and Plasmodium vivax malaria diagnosis in Butajira area, south-central Ethiopia - Malaria Journal

89 Altitude-Dependent and -Independent Variations in Plasmodium falciparum Prevalence in Northeastern Tanzania

90 The global distribution of clinical episodes of Plasmodium falciparum malaria

91 The global distribution of clinical episodes of Plasmodium falciparum malaria

92 Altitude-dependent and -independent variations in Plasmodium falciparum prevalence in northeastern Tanzania

93 Understanding dynamics of Plasmodium falciparum gametocytes production: Insights from an age-structured model

Keyword Connections

Journals

Research Groups

Bibliographies